IP Library Granted Patent US 12,650,704
Granted Patent B1
US 12,650,704 · App. 18/505,702 · Granted Jun 9, 2026

Oxygen mixing and delivery

Inventor: John C. Taube (Raleigh, NC)
Assignee: Vapotherm, Inc.
G05D11/13A61M16/024G05B13/0205A61M16/125A61M16/16A61M16/161A61M2202/0208A61M2205/13A61M2205/18A61M2205/3368A61M2205/502A61M2205/8206A61M2205/8262A61M2230/06A61M2230/205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,650,704
App. No.
18/505,702
Granted
Jun 9, 2026
Kind
B1
Abstract

An adaptive gas mixture controller system. A pulse oximeter interface receives pulse oximeter data. A gas blender interface communicates with a separate externally connected gas blender. A processor receives pulse oximeter data via the pulse oximeter interface and outputs data to the gas blender interface for adaptive feedback control of the gas mixture based upon the SpO 2 level signals from the pulse oximeter interface. When the processor receives data from the gas blender indicating that the gas mixture has been manually changed, enters a manual override mode and halts sending adaptive feedback control signals to the gas blender. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract.

Claims (34)

1 . A system for delivery of a breathing gas mixture to a patient, the system comprising:

a first input for connection with an oxygen source, the first input including a valve controlling the first input, the first input configured to receive an oxygen flow from the oxygen source at a first flow rate;

a second input for connection with a compressed air source, the second input configured to receive an air flow from the compressed air source at a second flow rate;

a blender to form, from the oxygen flow and the air flow, the breathing gas mixture at a third flow rate;

a humidifier for humidifying the breathing gas mixture, the humidifier configured to provide a water consumption rate of the humidifier;

a nasal cannula in fluid communication with the humidifier and configured to deliver the humidified breathing gas mixture to the patient;

a heated wire for heating the breathing gas mixture disposed upstream of the nasal cannula;

a pulse oximeter interface configured to receive signals from a pulse oximeter indicative of a first blood oxygen level of the patient;

a controller coupled to the valve and the pulse oximeter interface and having a memory;

wherein the controller is configured to:

receive, from the humidifier, a water consumption rate of the humidifier;

determine a current humidification level based on the third flow rate and the water consumption rate;

receive, from the pulse oximeter interface, the signals from the pulse oximeter indicative of the first blood oxygen level of the patient;

compare the signals indicative of the first blood oxygen level of the patient to a target blood oxygen level;

determine a first adjustment to be made to the first input;

actuate the valve to adjust the first input based on the first adjustment; and

receive new signals from the pulse oximeter interface indicative of a new blood oxygen level of the patient.

2 . The system of claim 1 , further comprising a delivery tube configured to convey a heated and humidified breathing gas mixture to the nasal cannula.

3 . The system of claim 1 , wherein the heated wire is disposed upstream of the humidifier.

4 . The system of claim 1 , wherein the humidifier comprises a water reservoir and a vaporization mechanism.

5 . The system of claim 4 , wherein the controller is coupled to the humidifier and configured to adjust a humidification level of the humidifier.

6 . The system of claim 1 , wherein the signals received at the pulse oximeter interface from the pulse oximeter include an SpO2 level of the patient.

7 . The system of claim 6 , wherein the signals received at the pulse oximeter interface from the pulse oximeter include a pulse rate of the patient.

8 . The system of claim 6 , wherein the memory stores a lookup table relating SpO2 levels to PaO2 levels, and the lookup table is derived from a sigmoid shaped oxyhemoglobin dissociation curve.

9 . The system of claim 8 , wherein the controller comprises a proportional integral derivative (PID) controller configured to track the sigmoid shaped oxyhemoglobin dissociation curve.

10 . The system of claim 9 , wherein the controller is further configured to:

convert an SpO2 level of the patient to a PaO2 level for calculation of an appropriate gas mixture.

11 . The system of claim 1 , wherein the valve is external to the system.

12 . The system of claim 1 , wherein the compressed air source is external to the system.

13 . The system of claim 1 , wherein first adjustment of the first input by the controller is configured to achieve a change in an oxygen percentage of the breathing gas mixture.

14 . The system of claim 13 , wherein the controller is configured to:

compare the new signals from the pulse oximeter indicative of the new blood oxygen level to the target blood oxygen level,

determine a second adjustment to be made to input of oxygen, and

actuate the valve to further adjust the input of oxygen to the patient based on the second adjustment.

Assignments (2)
SECURITY INTEREST Recorded Apr 20, 2026
From: VAPOTHERM, INC.
To: PERCEPTIVE CAPITAL SOLUTIONS HOLDINGS LP
Reel/Frame 075477/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2023
From: TAUBE, JOHN C.
To: VAPOTHERM, INC.
Reel/Frame 065519/0658 →
Continuity (4)
Continuation 17403192 · Aug 16, 2021
Continuation 16722722 · Dec 20, 2019
Continuation 16003508 · Jun 8, 2018
Continuation 14602392 · Jan 22, 2015
References Cited (150)
US 2414747A · Kirschbaum · 1947 [cited by applicant]
US 3734091A · Taplin · 1973 [cited by applicant]
US 4325413A · Lenhart et al. · 1982 [cited by applicant]
US 4584996A · Blum · 1986 [cited by applicant]
US 4665911A · Williams et al. · 1987 [cited by applicant]
US 4765340A · Sakai et al. · 1988 [cited by applicant]
US 4889116A · Taube · 1989 [cited by applicant]
US 5003985A · White et al. · 1991 [cited by applicant]
US 5103814A · Maher · 1992 [cited by applicant]
US 5178151A · Sackner · 1993 [cited by applicant]
US 5388575A · Taube · 1995 [cited by applicant]
US 6186142B1 · Schmidt et al. · 2001 [cited by applicant]
US 6561187B2 · Schmidt et al. · 2003 [cited by applicant]
US 7329038B2 · Hashiba · 2008 [cited by applicant]
US 7591632B2 · Baecke et al. · 2009 [cited by applicant]
US 7802571B2 · Tehrani · 2010 [cited by applicant]
US 8194944B2 · Tivig et al. · 2012 [cited by applicant]
US 8434481B2 · Ogilvie et al. · 2013 [cited by applicant]
US 8434483B2 · Patel et al. · 2013 [cited by applicant]
US 8434484B2 · Patel · 2013 [cited by applicant]
US 8434523B2 · Suharno · 2013 [cited by applicant]
US 8670811B2 · O'Reilly · 2014 [cited by applicant]
US 8720439B1 · Kolkowski et al. · 2014 [cited by applicant]
US 8801619B2 · Baker, Jr. et al. · 2014 [cited by applicant]
US 9272623B2 · Masuda · 2016 [cited by applicant]
US 9724025B1 · Kiani et al. · 2017 [cited by applicant]
US 9775570B2 · Al-Ali · 2017 [cited by applicant]
US 9788735B2 · Al-Ali · 2017 [cited by applicant]
US 10007238B1 · Taube · 2018 [cited by applicant]
US RE47218E · Al-Ali · 2019 [cited by applicant]
US 10514662B1 · Taube · 2019 [cited by applicant]
US 10532169B2 · Eberhard et al. · 2020 [cited by applicant]
US RE47882E · Al-Ali · 2020 [cited by applicant]
US 10674948B2 · Diab et al. · 2020 [cited by applicant]
US 11092984B1 · Taube · 2021 [cited by applicant]
US 11458270B2 · Landis · 2022 [cited by examiner]
US 11612706B2 · Taube · 2023 [cited by examiner]
US 12268817B2 · Niland · 2025 [cited by examiner]
US 20010035185A1 · Christopher · 2001 [cited by applicant]
US 20020017302A1 · Fukunaga et al. · 2002 [cited by applicant]
US 20030013980A1 · Starr et al. · 2003 [cited by applicant]
US 20030211244A1 · Li et al. · 2003 [cited by applicant]
US 20030216285A1 · Dumont et al. · 2003 [cited by applicant]
US 20040054261A1 · Kamataki et al. · 2004 [cited by applicant]
US 20040230108A1 · Melker et al. · 2004 [cited by applicant]
US 20050051168A1 · DeVries et al. · 2005 [cited by applicant]
US 20050109340A1 · Tehrani · 2005 [cited by applicant]
US 20050222503A1 · Dunlop et al. · 2005 [cited by applicant]
US 20050247311A1 · Vacchiano et al. · 2005 [cited by applicant]
US 20070137107A1 · Barnicki · 2007 [cited by applicant]
US 20080156328A1 · Taube · 2008 [cited by applicant]
US 20080183057A1 · Taube · 2008 [cited by applicant]
US 20090090363A1 · Niland et al. · 2009 [cited by applicant]
US 20090305214A1 · Pybus et al. · 2009 [cited by applicant]
US 20100175695A1 · Jamison · 2010 [cited by examiner]
US 20100224191A1 · Dixon et al. · 2010 [cited by applicant]
US 20110067697A1 · Lellouche et al. · 2011 [cited by applicant]
US 20110152648A1 · Rustick · 2011 [cited by applicant]
US 20110190611A1 · Rabi · 2011 [cited by applicant]
US 20110200392A1 · Moncrief, III · 2011 [cited by applicant]
US 20110319783A1 · Lindholt et al. · 2011 [cited by applicant]
US 20120016219A1 · Fujii · 2012 [cited by applicant]
US 20120090611A1 · Graboi et al. · 2012 [cited by applicant]
US 20120118285A1 · Wondka · 2012 [cited by examiner]
US 20120325207A1 · Fromage · 2012 [cited by applicant]
US 20130030267A1 · Lisogurski et al. · 2013 [cited by applicant]
US 20130174841A1 · McAuley et al. · 2013 [cited by applicant]
US 20130263855A1 · Tivig et al. · 2013 [cited by applicant]
US 20130276780A1 · Tobia et al. · 2013 [cited by applicant]
US 20140166005A1 · Tatkov et al. · 2014 [cited by applicant]
US 20150032029A1 · Al-Ali et al. · 2015 [cited by applicant]
US 20150059754A1 · Chbat et al. · 2015 [cited by applicant]
US 20150107588A1 · Cheung · 2015 [cited by examiner]
US 20150112169A1 · Lamego et al. · 2015 [cited by applicant]
US 20150320953A1 · Acker et al. · 2015 [cited by applicant]
US 20160029932A1 · Al-Ali · 2016 [cited by applicant]
US 20160121063A1 · Tatkov et al. · 2016 [cited by applicant]
US 20160193438A1 · White et al. · 2016 [cited by applicant]
US 20160213879A1 · Parthasarathy · 2016 [cited by examiner]
US 20160361508A1 · Cohen · 2016 [cited by applicant]
US 20170042488A1 · Muhsin · 2017 [cited by applicant]
US 20170143538A1 · Lee et al. · 2017 [cited by applicant]
US 20170312471A1 · Anger et al. · 2017 [cited by applicant]
US 20180146902A1 · Kiani et al. · 2018 [cited by applicant]
US 20180280645A1 · Lellouche · 2018 [cited by examiner]
US 20180310822A1 · Indorf et al. · 2018 [cited by applicant]
US 20190029578A1 · Al-Ali et al. · 2019 [cited by applicant]
US 20190192076A1 · McHale et al. · 2019 [cited by applicant]
US 20190200941A1 · Chandran et al. · 2019 [cited by applicant]
US 20200170513A1 · Walker · 2020 [cited by applicant]
US 20210128032A1 · Taube · 2021 [cited by examiner]
US 20210353158A1 · Landis · 2021 [cited by examiner]
US 20220331548A1 · Gulley · 2022 [cited by examiner]
US 20220347423A1 · Babbage · 2022 [cited by examiner]
US 20230022107A1 · Gulley · 2023 [cited by examiner]
US 20230277798A1 · Adametz · 2023 [cited by examiner]
US 20230321368A1 · Power · 2023 [cited by examiner]
US 20240033456A1 · Gray · 2024 [cited by examiner]
US 20240082521A1 · Gulley · 2024 [cited by examiner]
US 20240207553A1 · Gulley · 2024 [cited by examiner]
US 20240245874A1 · Leonard · 2024 [cited by examiner]
US 20240252772A1 · Lui · 2024 [cited by examiner]
US 20240277966A1 · Rapoport · 2024 [cited by examiner]
US 20240285887A1 · Taube · 2024 [cited by examiner]
US 20240379221A1 · Seekup · 2024 [cited by examiner]
US 20250025650A1 · Russell · 2025 [cited by examiner]
US 20250325766A1 · Gulley · 2025 [cited by examiner]
CA 2545570A1 · 2005 [cited by applicant]
CA 2691377A1 · 2009 [cited by applicant]
CA 2827253A1 · 2012 [cited by applicant]
WO 9624402 · 1996 [cited by applicant]
WO 2002056931A2 · 2002 [cited by applicant]
WO 2005038690A2 · 2005 [cited by applicant]
WO 2005051280A2 · 2005 [cited by applicant]
USPTO, Non-final Office Action for corresponding U.S. Appl. No. 18/482,460, mailed on Aug. 29, 2024, 14 pages. [cited by applicant]
Branson, et al., “Is Humidification Always Necessary During Noninvasive Ventilation in the Hospital?”, Respiratory Care, vol. 55, No. 2, Feb. 2010, 8 pages. [cited by applicant]
Anon., “Critical Care Therapy and Respiratory Care Section”, National Institutes of Health, 1112000, 4 pages. [cited by applicant]
Sano, et al., Adaptive control of arterial oxygen pressure of newborn infants under incubator oxygen treatments, IEE Proceeding, vol. 132, Pt. D., No. 5, Sep. 1985, 7 pages. [cited by applicant]
Anon., “Analog Dialogue: Pulse Oximeter”, Analog Devices, Inc., 1995-2014, 5 pages. [cited by applicant]
Soto, et al., “Automatic Ventilation Control”, Freescale.com/beyondbits, undated, downloaded Sep. 17, 2014, 3 pages. [cited by applicant]
Elleau, et al., “Helium-Oxygen mixture in respiratory distress syndrome: a double blind study”, J Pediatr., 122 (1):132-6, Abstract, Jan. 1993, 1 page. [cited by applicant]
Davies, et al., “Inspired Gas Temperature in Ventilated Neonates”, Pediatric Pulmonology 38:50-54, 2004, 8 pages. [cited by applicant]
Carter, et al., “Evaluation of heliox in children hospitalized with acute sever asthma. A randomized crossover trial”, Abstract, Chest, 109(5):1256-61, May 1996, 2 pages. [cited by applicant]
Adawy, et al., “Design of Fuzzy Controller for Supplying Oxygen in Sub-acute Respiratory Illnesses”, IJCSI, vol. 9, Issue 3, No. 1, May 2012, 15 pages. [cited by applicant]
Kass, et al., “Heliox therapy in acute severe asthma”, Abstract, Chest, 107(3):757-60, Mar. 1995, 2 pages. [cited by applicant]
Kudukis, et al., “Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children”, Abstract, J Pediatr., 130(2):217-24, Feb. 1997, 2 pages. [cited by applicant]
Lu, et al., “Helium-Oxygen in Treatment of Upper Airway Obstruction”, Anestheology, vol. 45, Dec. 1976, 3 pages. [cited by applicant]
Manthous, et al., “Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma”, Am J Respir Crit Care Med. Abstract, 151(2pt 1):310-4, Feb. 1995, 2 pages. [cited by applicant]
Martin-Barbaz, et al., “Use of helium oxygen mixtures in status asthmaticus”, Abstract, Rev Pneumol Clin. 43(4):186-9, 1987, 1 page. [cited by applicant]
Anon., “MR850 Respiratory Humidifier”, Fisher & Paykel, REF 185042343, Rev. J, Aug. 2012, 3 pages. [cited by applicant]
Anon., “Oxygen Saturation”, date unknown, downloaded Aug. 20, 2014, 4 pages. [cited by applicant]
Alkurawy, “Design of an Efficient Controller for Arterial Oxygen Saturation in Neonatal Infants”, PhD Thesis, University of Missouri-Columbia, Dec. 2013, 114 pages. [cited by applicant]
Sauder, et al., “Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant”, Abstract, South Med J. 84(5):646-8, May 1991, 1 page. [cited by applicant]
Shiue, et al., “The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis”, J Asthma, Abstract, 26(3):177-80, 1989, 1 page. [cited by applicant]
Swidwa, et al., “Helium-oxygen breathing in severe chronic obstructive pulmonary disease”, Abstract, Chest, 9=87 (6):790-5, Jun. 1985, 2 pages. [cited by applicant]
Panchal, et al., “Feedback-Controlled System to Titrate Oxygen Delivery”, Drexel University, Winter 2014, 41 pages. [cited by applicant]
Ardizzoni, “The incredible versatile op amp in medical apps”, Analog devices, Nov. 2, 2009, 3 pages. [cited by applicant]
Wolfson, et al., “Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia”, Abstract, J Pediatr., 104(5):752-7, May 1984, 1 page. [cited by applicant]
USPTO, Non-Final Rejection in U.S. Appl. No. 16/003,508, dated Jun. 27, 2019, 18 pages. [cited by applicant]
USPTO, Non-Final Rejection in U.S. Appl. No. 14/602,392, dated Oct. 3, 2017, 19 pages. [cited by applicant]
USPTO, Final Office Action in U.S. Appl. No. 14/602,392, dated Mar. 1, 2018, 22 pages. [cited by applicant]
ISA/EP; International Search Report and Written Opinion in International application No. PCT/US2020/057823, mailed Jan. 28, 2021, 12 pages. [cited by applicant]
ISA/RU; International Search Report and Written Opinion in International application No. PCT/US2020/062118, mailed Mar. 11, 2021, 7 pages. [cited by applicant]
USPTO, Non-Final Office Action in U.S. Appl. No. 16/722,722, dated Dec. 22, 2020, 24 pages. [cited by applicant]
WIPO, International Preliminary Report on Patentability for PCT Patent Application No. PCT/US2020/057823, dated May 10, 2022, 9 pages. [cited by applicant]
WIPO, International Preliminary Report on Patentability for PCT Patent Application No. PCT/US2020/062118, dated May 17, 2022, 6 pages. [cited by applicant]
USPTO; Non-Final Action for U.S. Appl. No. 16/672,638, dated Jul. 28, 2022, 15 pages. [cited by applicant]
USPTO; Final Action for U.S. Appl. No. 16/672,638, dated Dec. 9, 2022, 21 pages. [cited by applicant]
USPTO; Non-final Action for U.S. Appl. No. 17/403,192, dated Oct. 6, 2022, 32 pages. [cited by applicant]
USPTO; Final Action for U.S. Appl. No. 17/403,192, dated Mar. 21, 2023, 17 pages. [cited by applicant]